WHO Recommendations: Deworming in Children

Select Content Type
Briefs
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
Deworming children thmbnl
Detail Image
Deworming children mob det img
Book Detail
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

Soil-transmitted helminth (STH) infections—caused by roundworms, whipworms, and hookworms—are among the most common global infections, leading to anemia, intestinal issues, and poor nutrient absorption.

The WHO recommends annual or biannual deworming with albendazole (400 mg) or mebendazole (500 mg) for children aged 12 months to 12 years in areas where STH prevalence exceeds 20%, with biannual doses in regions above 50% prevalence.

While preventive chemotherapy remains vital, WHO stresses that lasting control depends on improving water, sanitation, and hygiene (WASH) infrastructure.

Published Date